NCT03062085

Brief Summary

The purpose of this study is to evaluate the long-term visual outcome of the cataract surgery using a large-scale and comprehensive database of high myopic cataract and age-related cataract patients. The investigators will further investigate into the various genetic and environmental factors that may contribute to the pathogenesis of high myopic cataract.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60,000

participants targeted

Target at P75+ for all trials

Timeline
179mo left

Started Jan 2015

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress44%
Jan 2015Dec 2040

Study Start

First participant enrolled

January 1, 2015

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

January 23, 2017

Completed
1 month until next milestone

First Posted

Study publicly available on registry

February 23, 2017

Completed
13.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2030

Expected
10 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2040

Last Updated

April 17, 2024

Status Verified

April 1, 2024

Enrollment Period

16 years

First QC Date

January 23, 2017

Last Update Submit

April 16, 2024

Conditions

Outcome Measures

Primary Outcomes (3)

  • Differences in the clinical phenotypes and visual outcomes of high myopic cataract patients

    Cataract type and severity of high myopic cataract patients are evaluated using LOCSIII grading system. Visual outcomes are also evaluated including visual acuity with or without correction, intraocular pressure, fundus function, contrast sensitivity and other visual outcome measurements.

    Follow-up until five years after surgery

  • Differences in the clinical phenotypes and visual outcomes of age-related cataract patients

    Cataract type and severity of age-related cataract patients are evaluated using LOCSIII grading system. Visual outcomes are also evaluated including visual acuity with or without correction, intraocular pressure, fundus function, contrast sensitivity and other visual outcome measurements.

    Follow-up until five years after surgery

  • Differences in the clinical phenotypes and visual outcomes of ametropic cataract patients

    Cataract type and severity of ametropic cataract patients are evaluated using LOCSIII grading system. Visual outcomes are also evaluated including visual acuity with or without correction, intraocular pressure, fundus function, contrast sensitivity and other visual outcome measurements.

    Follow-up until five years after surgery

Secondary Outcomes (1)

  • Genetic diversity based on biological specimen samples of three groups

    Analyzed within six months after surgery

Other Outcomes (3)

  • Difference in the surgical procedure of three groups

    Recorded on the surgery day for further analysis

  • Difference in the Diagnostic test of three groups

    Recorded before the surgery day for further analysis

  • Difference in the complications of the cataract surgery of three groups

    Follow-up until five years after surgery

Study Arms (3)

High myopic cataract group

Cataract patients with high myopia.

Other: Cataract

Age-related cataract group

Age-related cataract patients.

Other: Cataract

Ametropic cataract group

Cataract patients with ametropia.

Other: Cataract

Interventions

The genetic and environmental factors concerning to the pathogenesis of cataract in the three groups.

Age-related cataract groupAmetropic cataract groupHigh myopic cataract group

Eligibility Criteria

Age20 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Cataract patients who will undergo cataract surgery in Eye and ENT Hospital of Fudan University.

You may qualify if:

  • Clinical diagnosis of cataract
  • Must be able to cooperate with the ophthalmic examination

You may not qualify if:

  • Clinical diagnosis of mental illness
  • Mentally disabled

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Eye and ENT Hospital of Fudan University

Shanghai, Shanghai Municipality, 200031, China

RECRUITING

Related Publications (6)

  • Zhang Y, Zhang S, Zhang K, Lu Y, Zhu X. Characteristics of the Corneal Endothelium in Elderly Adults with High Myopia. Phenomics. 2025 Jan 27;4(6):562-569. doi: 10.1007/s43657-024-00186-6. eCollection 2024 Dec.

  • Hu X, Qi J, Cheng K, He W, Zhang K, Zhao C, Lu Y, Zhu X. Effectiveness of prophylactic capsular tension ring implantation during cataract surgery in highly myopic eyes. J Cataract Refract Surg. 2024 Oct 1;50(10):1030-1036. doi: 10.1097/j.jcrs.0000000000001495.

  • He W, Wei L, Liu S, Huang Z, Qi J, Zhang K, Meng J, Du Y, Lu Y, Zhu X. Role of Optic Nerve Head Characteristics in Predicting Intraocular Pressure Spikes after Cataract Surgery in Highly Myopic Eyes. Ophthalmol Ther. 2023 Aug;12(4):2023-2033. doi: 10.1007/s40123-023-00714-z. Epub 2023 May 13.

  • He W, Cheng K, Zhao L, Liu S, Huang Z, Zhang K, Du Y, Zhou X, Lu Y, Zhu X. Long-Term Outcomes of Posterior Capsular Opacification in Highly Myopic Eyes and Its Influencing Factors. Ophthalmol Ther. 2023 Aug;12(4):1881-1891. doi: 10.1007/s40123-023-00711-2. Epub 2023 May 3.

  • Meng J, Chen Y, Cheng K, Qi J, Du Y, Yao Y, He W, Zhang K, Lu Y, Zhu X. LONG-TERM PROGRESSION PATTERN OF MYOPIC TRACTIONAL MACULOPATHY: Outcomes and Risk Factors. Retina. 2023 Jul 1;43(7):1189-1197. doi: 10.1097/IAE.0000000000003791.

  • Lu Q, He W, Qian D, Lu Y, Zhu X. Measurement of crystalline lens tilt in high myopic eyes before cataract surgery using swept-source optical coherence tomography. Eye Vis (Lond). 2020 Mar 6;7:14. doi: 10.1186/s40662-020-00176-5. eCollection 2020.

Biospecimen

Retention: SAMPLES WITH DNA

Blood samples from HMC, ARC and anisometropia patients collected before the cataract surgery. Aqueous humor and capsular membranes samples from HMC, ARC and ametropic cataract patients collected during the cataract surgery.

MeSH Terms

Conditions

CataractAnticipation, Genetic

Interventions

Cataract Extraction

Condition Hierarchy (Ancestors)

Lens DiseasesEye DiseasesGenetic Predisposition to DiseaseDisease SusceptibilityDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Refractive Surgical ProceduresOphthalmologic Surgical ProceduresSurgical Procedures, Operative

Study Officials

  • Yi Lu, M.D.

    Eye and ENT Hospital of Fudan University

    STUDY CHAIR
  • Xiangjia Zhu, M.D.

    Eye and ENT Hospital of Fudan University

    STUDY DIRECTOR
  • Keke Zhang, M.D.

    Eye and ENT Hospital of Fudan University

    PRINCIPAL INVESTIGATOR
  • Wenwen He, M.D.

    Eye and ENT Hospital of Fudan University

    PRINCIPAL INVESTIGATOR
  • Yu Du, B.S.

    Eye and ENT Hospital of Fudan University

    PRINCIPAL INVESTIGATOR
  • Yinglei Zhang, M.D.

    Eye and ENT Hospital of Fudan University

    PRINCIPAL INVESTIGATOR
  • Zhennan Zhao, Ph.D.

    Eye and ENT Hospital of Fudan University

    PRINCIPAL INVESTIGATOR
  • Ruiqi Chang, B.S.

    Eye and ENT Hospital of Fudan University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Target Duration
5 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 23, 2017

First Posted

February 23, 2017

Study Start

January 1, 2015

Primary Completion (Estimated)

December 31, 2030

Study Completion (Estimated)

December 31, 2040

Last Updated

April 17, 2024

Record last verified: 2024-04

Locations